search results for
View all search results
Home
Contact
Help
Deutsch
RSS
Download Report
Font Size
The Fresenius group
To our shareholders
Fresenius group in figures (U.S. GAAP)
Summary of the fiscal year
Fresenius share
Stock markets
Capital structure
ADR program
Stock conversion and change of legal form
Dividend
Shareholder structure
Share Key data
Analysts recommendations
Investor relations
Business segments
Fresenius Medical Care
Fresenius Kabi
Fresenius Helios
Fresenius Vamed
Fresenius worldwide
Transparency & Governance
Report of the Supervisory Board
Corporate Governance Declaration
Group Management and Supervision Structure
Corporate Bodies
Shareholders
Annual General Meeting
Management Board and Supervisory Board Procedures
Composition and Procedures of the Supervisory Board Committees
Relevant Disclosures on Corporate Governance Practices
Compliance
Risk Management and Control System
German Corporate Governance and Declaration of Conformity
Further Information on Corporate Governance
Diversity
Avoidance of Conflicts of Interest
Directors’ Dealings
Transparency and Communication
Financial accounting and reporting
Compensation Report
Compensation of the Management Board
Commitments to Members of the Management Board for the Event of the Termination of their Appointment
Miscellaneous
Compensation of the Supervisory Board
Directors & Officers Insurance
Boards
Supervisory board Fresenius SE & Co. KGaA
Committees of the supervisory board
Management Board Fresenius Management SE
Supervisory Board Fresenius Management SE
Management Report
Operations and business environment
Group structure and business
Management and control
Key products and services
Important markets and competitive position
Legal and economic factors
Capital, shareholders, articles of association
Corporate performance criteria, goals, and strategy
Strategy and goals
Overall business development
Economic environment
Health care industry
The Management Board’s assessment of the effect of general economic developments
Significant factors affecting operating performance
The Management Board’s assessment of the business results
Comparison of the actual business results with the forecasts
Results of operations, financial position, assets and liabilities
Results of operations
Sales
Earnings structure
Reconciliation to Group net income
Development of other major items in the statement of income
Value added
Financial position
Financial management policies and goals
Financing
Effect of off-balance-sheet financing instruments on our financial position and assets and liabilities
Liquidity analysis
Dividend
Cash flow analysis
Investments and acquisitions
Assets and liabilities
Asset and liability structure
Currency and interest risk management
Non-financial performance indicators and other success factors
Employees
Human Resources Management
Talent Management
Personnel Development
Personnel Marketing
Vocational Training Management
Profit-Sharing Scheme and Stock Option Plan
Research and development
Fresenius Medical Care
Fresenius Kabi
Fresenius Biotech
Procurement
Fresenius Medical Care
Fresenius Kabi
Fresenius Helios
Fresenius Vamed
Quality management
Fresenius Medical Care
Fresenius Kabi
Fresenius Helios
Fresenius Vamed
Responsibility, environmental management, sustainability
Fresenius Medical Care
Fresenius Kabi
Fresenius Helios
Fresenius Vamed
Sales, marketing, and logistics
Overall assessment of the business situation
Opportunities and risk report
Opportunities management
Risk management
Risk areas
General Economic Risks
Risks in the General Operating Framework
Risks in the Health Care Sector
Operating Risks
Assessment of overall risk
Corporate rating
Subsequent events
Outlook
General and mid-term outlook
Future markets
Economic outlook
Health care sector and markets
Group sales and earnings
Sales and earnings by business segment
Financing
Investments
Procurement
Research and development
Corporate structure and organization
Planned changes in human resources and the social area
Dividend
Financial Statements
Consolidated statement of income
Consolidated statement of comprehensive income
Consolidated statement of financial position
Consolidated statement of cash flows
Consolidated statement of changes in equity
Consolidated segment reporting
Notes
General notes
1. Principles
2. Acquisitions, divestitures and investments
Notes on the consolidated statement of income
3. Special items
4. Sales
5. Cost of sales
6. Cost of materials
7. Personnel expenses
8. Selling, general and administrative expenses
9. Net interest
10. Other financial result
11. Taxes
12. Earnings per share
Notes on the consolidated statement of financial position
13. Cash and cash equivalents
14. Trade accounts receivable
15. Inventories
16. Other current and non-current assets
17. Property, plant and equipment
18. Goodwill and other intangible assets
19. Other accrued expenses
20. Other liabilities
21. Debt and capital lease obligations
22. Senior Notes
23. Mandatory Exchangeable Bonds
24. Trust preferred securities
25. Pensions and similar obligations
26. Noncontrolling interest
27. Fresenius SE & Co. KGaA shareholders’ equity
28. Other comprehensive income (loss)
Other notes
29. Commitments and contingent liabilities
30. Financial instruments
31. Supplementary information on capital management
32. Supplementary information on the consolidated statement of cash flows
33. Notes on the consolidated segment reporting
34. Stock options
35. Related party transactions
36. Subsequent events
Notes in accordance with the German Commercial Code (HGB)
37. Compensation of the Management Board and the Supervisory Board
38. Auditor’s fees
39. Corporate Governance
40. Proposal for the distribution of earnings
41. Responsibility statement
Auditor’s Report
no content defined!
